Making an informed choice: Which breast reconstruction type has the lowest complication rate?
Autologous tissue reconstruction
Breast implant
Complications
Mastectomy
Reconstruction
Journal
American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
16
03
2019
revised:
12
09
2019
accepted:
25
09
2019
pubmed:
14
10
2019
medline:
10
3
2020
entrez:
14
10
2019
Statut:
ppublish
Résumé
The aim of this study was to investigate long-term breast reconstruction outcomes at a single institution in order to offer data-driven counseling for patients. A retrospective review was performed of 399 patients who underwent mastectomy with 1-stage implant-based breast reconstruction (IBBR), 2-stage IBBR, or autologous tissue reconstruction (ATR) for invasive breast cancer or ductal carcinoma in situ at our institution from 2010 to 2017. Complications were classified as major for any unplanned return to the operating room (OR). Overall complication rates were similar among 1-stage IBBR (59%), 2-stage IBBR (60%), and ATR (52%, p = 0.54). Factors independently associated with major complications were diabetes (OR = 25.4 95% CI: 3.2-202.4; p = 0.002), and 1-stage IBBR vs. ATR (1-stage: OR = 2.0 95% CI: 1.0-4.0; p = 0.04). Bilateral procedures were also at increased risk of major complications on univariate analysis (OR = 1.59 95% CI: 1.0-2.5; p = 0.04). Long-term breast reconstruction complication rates are higher than previously anticipated. Patients should be counseled that IBBR is associated with higher rates of complications, including unplanned return to the OR, compared to ATR.
Identifiants
pubmed: 31606126
pii: S0002-9610(19)30356-3
doi: 10.1016/j.amjsurg.2019.09.033
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1040-1045Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.